Fixed Phage invests in continued improvement to Glasgow facilities

DATE: 16th December 2022

Following an extensive laboratory and office improvement project in 2021, the company has further invested in facilities in Q4 2022.

The programme has involved undertaking extensive improvements of additional laboratories ensuring safety and quality compliance, with maximal productivity.  The completion of this work provides a facility that will be able to support increased capacity and capability in current development projects as well as future project needs.


Chris Bindon, Operations Director for Fixed Phage said: 

Fixed Phage is committed to continuous improvement in our skills and training, facilities and capabilities through our core technology programme, professional development, and capital investment. These are key to scaling the company’s activities and continued success in the development and commercialisation of phage solutions and are fundamental to supporting our current and future programmes.   

Related Articles